Bio-Rad Laboratories Inc. - Class A (BIO) Company Profile & Statistics

Bio-Rad Laboratories Inc. - Class A
BIO
(NYSE)
Open
307.94
-12.37 (-3.86%)
in:usd•As of: Nov 18, 2024 12:38 UTC -5
Open
317.98
High
317.98
Low
306.78

About Bio-Rad Laboratories Inc. - Class A

CEO

Norman Schwartz

Headquarters

1000 alfred nobel drive

hercules, ca 94547, united states

Auditor

KPMG LLP

Employees

8,030

Share Holders

232

Website

www.bio rad.com

Industry

medical specialties

Sector

health technology

Company Overview

Bio-Rad Laboratories is a manufacturer and global supplier of clinical diagnostics and life science research products in the healthcare, analytical chemistry life science research and other markets. It offers a wide portfolio of products and systems which allow the separation of complex chemical and biological materials and discovery, analysis and purification of their components. Bio-Rad has extensive and direct distribution channels outside the United States through subsidiaries which focus on sales, customer service and product distribution. The company operates through two reportable segments - Life Science segment which designs, manufactures, markets and services reagents, apparatus and instruments utilized for biological research. Clinical Diagnostics - This business markets and distributes products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians office laboratories, transfusion laboratories as well as insurance and forensic testing laboratories.

Bio-Rad Laboratories Inc. - Class A Statistics

Valuation Measures

Market Capitalization ²	8.97B
Enterprise Value	9.76B
Enterprise Value/EBITDA (ttm)	31.89
Price to Earnings Ratio (ttm)	30.48
Price to Book (mrq)	1.20
Price to Sales (ttm)	3.48
Price to Cash (ytd)	26.46

Profitability

Gross Margin (ttm)	54.39%
Operating Margin (ttm)	11.60%
Profit Margin (ttm)	-31.11%
Return on Equity (ttm)	3.74%
Return on Invested Capital (ttm)	-12.36%
Return on Assets (ttm)	2.65%

Income Statement

Revenue (ttm)	2.58B
Revenue Per Share (ttm)	92.16
Gross Profit (ttm)	1.40B
EBITDA (ttm)³	305.99M
Net Income Avi to Common (ttm)	-778.69M
Diluted EPS (ttm)	-27.33

Share Statistics

Beta (5Y Monthly)	0.93
52-Week Change	1.12%
S&P500 52-Week Change	29.68%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	28.00M
Dividend Yield	0.00%
Float ⁴	23.10M
% Held by Insiders	17.50%
% Held by Institutions	65.24%

Balance Sheet

Total Cash (mrq)	1.63B
Total Cash Per Share (mrq)	58.15
Total Debt (mrq)	1.20B
Total Debt/Equity (mrq)	16.04%
Current Ratio (mrq)	6.14%
Quick Ratio (mrq)	4.52%
Book Value Per Share (mrq)	267.46

Cash Flow

Operating Cash Flow Per Share (ytd)	11.83
Free Cash Flow (ytd)	208.51M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Bio-Rad Laboratories Inc. - Class A

Trade With A Regulated Broker